ABUS vs ED
Arbutus Biopharma Corp (ABUS) versus Consolidated Edison Inc (ED) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported ED revenue for 2024-12-31 was $15.26B. Net income was $1.82B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. ED currently screens at market cap $36.02B and trailing P/E 18.3.
Not investment advice. Open the ABUS and ED stock pages for the full models.
Not investment advice.